Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma

被引：0
|
作者：
Wittlinger, M
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 121
页数：3
相关论文
共 50 条
  • [31] Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: A retrospective study
    Katano, Atsuto
    Takahashi, Wataru
    Yamashita, Hideomi
    Yamamoto, Kentaro
    Ando, Mizuo
    Yoshida, Masafumi
    Saito, Yuki
    Abe, Osamu
    Nakagawa, Keiichi
    MEDICINE, 2018, 97 (18)
  • [32] Weekly cisplatin administration concurrent with radiation therapy for locoregionally advanced nasopharyngeal carcinoma
    Isobe K.
    Uno T.
    Aruga T.
    Kawakami H.
    Ueno N.
    Hanazawa T.
    Okamoto Y.
    Ito H.
    International Journal of Clinical Oncology, 2005, 10 (3) : 201 - 203
  • [33] Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
    Lee, Anne W. M.
    Tung, Stewart Y.
    Chua, Daniel T. T.
    Ngan, Roger K. C.
    Chappell, Rick
    Tung, Raymond
    Siu, Lillian
    Ng, W. T.
    Sze, W. K.
    Au, Gordon K. H.
    Law, Stephen C. K.
    O'Sullivan, Brian
    Yau, T. K.
    Leung, T. W.
    Au, Joseph S. K.
    Sze, W. M.
    Choi, C. W.
    Fung, K. K.
    Lau, Joseph T.
    Lau, W. H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (15): : 1188 - 1198
  • [34] Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Xiayun, He
    Ou, Dan
    Ying, Hongmei
    Zhu, Guopei
    Hu, Chaosu
    Liu, Taifu
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (03) : 1027 - 1033
  • [35] Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
    Hong, RL
    Ting, LL
    Ko, JY
    Hsu, MM
    Sheen, TS
    Lou, PJ
    Wang, CC
    Chung, NN
    Lui, LT
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) : 4305 - 4313
  • [36] Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma
    He Xiayun
    Dan Ou
    Hongmei Ying
    Guopei Zhu
    Chaosu Hu
    Taifu Liu
    European Archives of Oto-Rhino-Laryngology, 2012, 269 : 1027 - 1033
  • [37] Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma
    Liu, C. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E580 - E580
  • [38] Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
    Liu, Li-Ting
    Liang, Yu-Jing
    Guo, Shan-Shan
    Mo, Hao-Yuan
    Guo, Ling
    Wen, Yue-Feng
    Xie, Hao-Jun
    Tang, Qing-Nan
    Sun, Xue-Song
    Liu, Sai-Lan
    Li, Xiao-Yun
    Yang, Jin-Hao
    Yang, Zhen-Chong
    Tang, Lin-Quan
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [39] Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
    Uchinami, Yusuke
    Yasuda, Koichi
    Minatogawa, Hideki
    Dekura, Yasuhiro
    Nishikawa, Noboru
    Kinoshita, Rumiko
    Nishioka, Kentaro
    Katoh, Norio
    Mori, Takashi
    Otsuka, Manami
    Miyamoto, Naoki
    Suzuki, Ryusuke
    Kobashi, Keiji
    Shimizu, Yasushi
    Taguchi, Jun
    Tsushima, Nayuta
    Kano, Satoshi
    Homma, Akihiro
    Aoyama, Hidefumi
    RADIATION ONCOLOGY JOURNAL, 2024, 42 (01): : 74 - 82
  • [40] Phase II: Concurrent cisplatin/radiotherapy followed by adjuvant cisplatin/docetaxel for locally advanced nasopharyngeal carcinoma.
    Kandil, MS
    Nasser, HS
    Ammar, FA
    Bandey, SA
    Asiri, MA
    Zahrani, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 518S - 518S
12345